These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16290935)

  • 61. Probing PARP1-inhibitor complexes for the development of novel inhibitors.
    Saqib U; Baig MS
    Cell Mol Biol (Noisy-le-grand); 2014 Oct; 60(3):43-52. PubMed ID: 25346248
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The discovery and synthesis of novel adenosine substituted 2,3-dihydro-1H-isoindol-1-ones: potent inhibitors of poly(ADP-ribose) polymerase-1 (PARP-1).
    Jagtap PG; Southan GJ; Baloglu E; Ram S; Mabley JG; Marton A; Salzman A; Szabó C
    Bioorg Med Chem Lett; 2004 Jan; 14(1):81-5. PubMed ID: 14684303
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Discovery of a novel allosteric inhibitor scaffold for polyadenosine-diphosphate-ribose polymerase 14 (PARP14) macrodomain 2.
    Moustakim M; Riedel K; Schuller M; Gehring AP; Monteiro OP; Martin SP; Fedorov O; Heer J; Dixon DJ; Elkins JM; Knapp S; Bracher F; Brennan PE
    Bioorg Med Chem; 2018 Jul; 26(11):2965-2972. PubMed ID: 29567296
    [TBL] [Abstract][Full Text] [Related]  

  • 64. In silico identification of poly(ADP-ribose)polymerase-1 inhibitors and their chemosensitizing effects against cisplatin-resistant human gastric cancer cells.
    Le TV; Suh JH; Kim N; Park HJ
    Bioorg Med Chem Lett; 2013 May; 23(9):2642-6. PubMed ID: 23522835
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Synthesis, structure-activity relationship, and biological studies of indolocarbazoles as potent cyclin D1-CDK4 inhibitors.
    Zhu G; Conner SE; Zhou X; Shih C; Li T; Anderson BD; Brooks HB; Campbell RM; Considine E; Dempsey JA; Faul MM; Ogg C; Patel B; Schultz RM; Spencer CD; Teicher B; Watkins SA
    J Med Chem; 2003 May; 46(11):2027-30. PubMed ID: 12747775
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Design and synthesis of poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors. Part 3: In vitro evaluation of 1,3,4,5-tetrahydro-benzo[c][1,6]- and [c][1,7]-naphthyridin-6-ones.
    Ferraris D; Ficco RP; Pahutski T; Lautar S; Huang S; Zhang J; Kalish V
    Bioorg Med Chem Lett; 2003 Aug; 13(15):2513-8. PubMed ID: 12852955
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Synthesis of 3-substituted benzamides and 5-substituted isoquinolin-1(2H)-ones and preliminary evaluation as inhibitors of poly(ADP-ribose)polymerase (PARP).
    Watson CY; Whish WJ; Threadgill MD
    Bioorg Med Chem; 1998 Jun; 6(6):721-34. PubMed ID: 9681138
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Discovery and structure-activity relationship of novel 2,3-dihydrobenzofuran-7-carboxamide and 2,3-dihydrobenzofuran-3(2H)-one-7-carboxamide derivatives as poly(ADP-ribose)polymerase-1 inhibitors.
    Patel MR; Bhatt A; Steffen JD; Chergui A; Murai J; Pommier Y; Pascal JM; Trombetta LD; Fronczek FR; Talele TT
    J Med Chem; 2014 Jul; 57(13):5579-601. PubMed ID: 24922587
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Design and synthesis of potent inhibitors of the mono(ADP-ribosyl)transferase, PARP14.
    Upton K; Meyers M; Thorsell AG; Karlberg T; Holechek J; Lease R; Schey G; Wolf E; Lucente A; Schüler H; Ferraris D
    Bioorg Med Chem Lett; 2017 Jul; 27(13):2907-2911. PubMed ID: 28495083
    [TBL] [Abstract][Full Text] [Related]  

  • 70. PARP inhibitor with selectivity toward ADP-ribosyltransferase ARTD3/PARP3.
    Lindgren AE; Karlberg T; Thorsell AG; Hesse M; Spjut S; Ekblad T; Andersson CD; Pinto AF; Weigelt J; Hottiger MO; Linusson A; Elofsson M; Schüler H
    ACS Chem Biol; 2013 Aug; 8(8):1698-703. PubMed ID: 23742272
    [TBL] [Abstract][Full Text] [Related]  

  • 71. New poly(ADP-ribose) polymerase-1 inhibitors with antioxidant activity based on 4-carboxamidobenzimidazole-2-ylpyrroline and -tetrahydropyridine nitroxides and their precursors.
    Kálai T; Balog M; Szabó A; Gulyás G; Jeko J; Sümegi B; Hideg K
    J Med Chem; 2009 Mar; 52(6):1619-29. PubMed ID: 19245212
    [TBL] [Abstract][Full Text] [Related]  

  • 72. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1.
    Menear KA; Adcock C; Boulter R; Cockcroft XL; Copsey L; Cranston A; Dillon KJ; Drzewiecki J; Garman S; Gomez S; Javaid H; Kerrigan F; Knights C; Lau A; Loh VM; Matthews IT; Moore S; O'Connor MJ; Smith GC; Martin NM
    J Med Chem; 2008 Oct; 51(20):6581-91. PubMed ID: 18800822
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Synthesis and biological evaluation of isoindoloisoquinolinone, pyroloisoquinolinone and benzoquinazolinone derivatives as poly(ADP-ribose) polymerase-1 inhibitors.
    Suyavaran A; Ramamurthy C; Mareeswaran R; Shanthi YV; Selvakumar J; Mangalaraj S; Kumar MS; Ramanathan CR; Thirunavukkarasu C
    Bioorg Med Chem; 2015 Feb; 23(3):488-98. PubMed ID: 25555733
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Poly(ADP-ribose) polymerase (PARP) inhibition or PARP-1 gene deletion reduces angiogenesis.
    Tentori L; Lacal PM; Muzi A; Dorio AS; Leonetti C; Scarsella M; Ruffini F; Xu W; Min W; Stoppacciaro A; Colarossi C; Wang ZQ; Zhang J; Graziani G
    Eur J Cancer; 2007 Sep; 43(14):2124-33. PubMed ID: 17714938
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Inhibition of poly (ADP-ribose) polymerase activates ATM which is required for subsequent homologous recombination repair.
    Bryant HE; Helleday T
    Nucleic Acids Res; 2006; 34(6):1685-91. PubMed ID: 16556909
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Influence of usnic acid and its derivatives on the activity of mammalian poly(ADP-ribose)polymerase 1 and DNA polymerase β.
    Zakharenko A; Sokolov D; Luzina O; Sukhanova M; Khodyreva S; Zakharova O; Salakhutdinov N; Lavrik O
    Med Chem; 2012 Sep; 8(5):883-93. PubMed ID: 22741606
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Synthesis of 4-alkyl-, 4-aryl- and 4-arylamino-5-aminoisoquinolin-1-ones and identification of a new PARP-2 selective inhibitor.
    Sunderland PT; Dhami A; Mahon MF; Jones LA; Tully SR; Lloyd MD; Thompson AS; Javaid H; Martin NM; Threadgill MD
    Org Biomol Chem; 2011 Feb; 9(3):881-91. PubMed ID: 21127791
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Adenosine thiamine triphosphate (AThTP) inhibits poly(ADP-ribose) polymerase-1 (PARP-1) activity.
    Tanaka T; Yamamoto D; Sato T; Tanaka S; Usui K; Manabe M; Aoki Y; Iwashima Y; Saito Y; Mino Y; Deguchi H
    J Nutr Sci Vitaminol (Tokyo); 2011; 57(2):192-6. PubMed ID: 21697640
    [TBL] [Abstract][Full Text] [Related]  

  • 79. An enzymatic assay for poly(ADP-ribose) polymerase-1 (PARP-1) via the chemical quantitation of NAD(+): application to the high-throughput screening of small molecules as potential inhibitors.
    Putt KS; Hergenrother PJ
    Anal Biochem; 2004 Mar; 326(1):78-86. PubMed ID: 14769338
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Development of a miniaturized assay for the high-throughput screening program for poly(ADP-ribose) polymerase-1.
    Lee S; Koo HN; Lee BH
    Methods Find Exp Clin Pharmacol; 2005 Nov; 27(9):617-22. PubMed ID: 16357945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.